Researchers have a new process for developing dendritic cell-based immunotherapies for HIV. They have demonstrated that loading monocyte-derived dendritic cells with combinations of HIV antigen RNA stimulates the expansion of HIV-specific T cells, which attack and kill HIV-infected cells.